This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q65377547
rdf:type
wikibase:Item
schema:description
clinical trial klinisch onderzoek ensayu clínicu клінічне випробування
rdfs:label
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
skos:prefLabel
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
schema:name
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
p:P1476
wds:Q65377547-C31F2211-B627-4A56-B45A-FA86B995934D
wdt:P1476
Randomized Phase II Study of Pre-operative Chemoradiotherapy +/- Panitumumab (IND #110152) Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIA, N2+) Non-Small Cell Lung Cancer
p:P582
wds:Q65377547-D51E3E32-65D2-412D-8A08-963D482DFE4E
wdt:P582
2015-12-01T00:00:00Z
p:P31
wds:Q65377547-C8F530D5-0637-4AFD-B8D2-53EF72D9657B
wdt:P31
wd:Q30612
p:P580
wds:Q65377547-7702381F-9706-4F3B-ADFF-F9238DF6875A
wdt:P580
2011-02-01T00:00:00Z
p:P17
wds:Q65377547-8698167C-FE6C-4264-B74F-803708003D06
wdt:P17
wd:Q30
p:P6153
wds:Q65377547-4C72D331-2D29-4B7F-AA1A-FD83B0592177 wds:Q65377547-2D9051AD-EC6E-416E-981E-9E070485E094 wds:Q65377547-B76D2BC6-891A-4F80-A689-21386ADEB11F
wdt:P6153
wd:Q1360303 wd:Q4980899 wd:Q61676534
p:P4844
wds:Q65377547-547B301C-22C4-415B-8139-E278603D98D4 wds:Q65377547-3277D30D-0C69-4B07-8800-FA224E61FAE0
wdt:P4844
wd:Q423762 wd:Q415588
p:P2899
wds:Q65377547-8F67E596-AE18-43B1-B630-2995CB2BF412
wdt:P2899
18
p:P859
wds:Q65377547-018D6ADA-863E-44CA-A8D8-ED2CDE76A6F4
wdt:P859
wd:Q7280340
p:P1132
wds:Q65377547-62D10B6C-4EED-4EF2-B74E-C07D00CADCEA
wdt:P1132
71
p:P8363
wds:Q65377547-5528D031-324B-4BDC-98D5-6AD290DF6AED
wdt:P8363
wd:Q78089383
p:P3098
wds:Q65377547-035C99E1-F751-487D-BBDD-AEF1F47341C3
wdt:P3098
NCT00979212
p:P6099
wds:Q65377547-7CC82C09-D3D7-4844-9689-6919E3C9132B
wdt:P6099
wd:Q42824440